Advertisement

Interest in Over-the-Counter Access to a Progestin-Only Pill among Women in the United States

  • Kate Grindlay
    Correspondence
    Correspondence to: Kate Grindlay, MSPH, Ibis Reproductive Health, 2067 Massachusetts Avenue, Suite 320, Cambridge, MA 02140. Phone: +1-617-349-0040; fax: +1-617-349-0041.
    Affiliations
    Ibis Reproductive Health, Cambridge, Massachusetts
    Search for articles by this author
  • Daniel Grossman
    Affiliations
    Advancing New Standards in Reproductive Health (ANSIRH), Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, Oakland, California
    Search for articles by this author
Published:January 29, 2018DOI:https://doi.org/10.1016/j.whi.2017.11.006

      Abstract

      Background

      A progestin-only pill may be the first pill formulation to become available over the counter in the United States; however, no research on over-the-counter (OTC) pill interest has focused on progestin-only pills or a representative sample of teens. The objective of this study was to assess U.S. women and teens’ interest in OTC progestin-only pill use.

      Methods

      In October 2015, we conducted a nationally representative, cross-sectional, online survey with 2,026 sexually active adult women aged 18 to 44 not currently desiring pregnancy, and 513 female teens aged 15 to 17. Logistic regression was used to identify characteristics associated with likely OTC progestin-only pill use. We also assessed reasons for use or nonuse, duration of use, and willingness to pay.

      Results

      Thirty-nine percent of adults and 29% of teens reported likely use, with a greater likelihood if covered by insurance. Adults were willing to pay $15 per month and teens $10 per month on average. Among adults, women who were never married or living alone (vs. married), uninsured (vs. privately insured), current pill or less effective method users (vs. ring, patch, injectable, or intrauterine device), tried to get a birth control prescription in the past year, or ever used an oral contraceptive pill or progestin-only pill had higher odds of likely use. Among teens, Spanish speakers and those who ever had sex had higher odds of likely use; Black teens (vs. White) had lower odds.

      Conclusions

      Teens and adults are interested in using an OTC progestin-only pill. These findings indicate a large pool of interested users and the potential for improved contraceptive access by making an OTC progestin-only pill available.
      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Women's Health Issues
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Academy of Family Physicians
        Over-the-counter oral contraceptives.
        (Available:) (Accessed: May 1, 2017)
        • American College of Obstetricians and Gynecologists
        Committee opinion no 544: Over-the-counter access to oral contraceptives.
        Obstetrics & Gynecology. 2012; 120: 1527-1531
        • American Medical Association
        Committee Resolution D-75.995: Over-the-counter access to oral contraceptives.
        2013 (Available:) (Accessed: May 1, 2017)
        • Bedsider
        Maryland takes birth control coverage to the next level.
        2016 (Available:) (Accessed: May 1, 2017)
        • Bureau of the Census for the Bureau of Labor Statistics
        Current Population Survey supplement data.
        Author, Washington, DC2014
        • Callegaro M.
        • Disogra C.
        Computing response metrics for online panels.
        Public Opinion Quarterly. 2008; 72: 1008-1031
        • Callegaro M.
        • Villar A.
        • Krosnick J.A.
        • Yeager D.
        A critical review of studies investigating the quality of data obtained with online panels.
        in: Callegaro M. Baker R. Bethlehem J. Göritz A. Krosnick J.A. Lavrakas P.J. Online panel research: A data quality perspective. John Wiley and Sons, New York2014
        • Centers for Disease Control and Prevention
        National survey of family growth. 2011–2013 NSFG: Public use data files, codebooks, and documentation.
        (Available:) (Accessed: May 1, 2017)
        • Curtis K.M.
        • Tepper N.K.
        • Jatlaoui T.C.
        • Berry-Bibee E.
        • Horton L.G.
        • Zapata L.B.
        • Whiteman M.K.
        US medical eligibility criteria for contraceptive use, 2016.
        Morbidity and Mortality Weekly Report. 2016; 65: 1-104
        • Department of Health and Human Services
        Annual update of the HHS poverty guidelines.
        Federal Register. 2015; 80: 3236-3237
        • Finer L.B.
        • Zolna M.R.
        Declines in unintended pregnancy in the United States, 2008–2011.
        New England Journal of Medicine. 2016; 374: 843-852
        • Grindlay K.
        • Burns B.
        • Grossman D.
        Prescription requirements and over-the-counter access to oral contraceptives: A global review.
        Contraception. 2013; 88: 91-96
        • Grindlay K.
        • Grossman D.
        Prescription birth control access among U.S. women at risk of unintended pregnancy.
        Journal of Women's Health. 2016; 25: 249-254
        • Grossman D.
        Over-the-counter access to oral contraceptives.
        Obstetrics & Gynecology Clinics of North America. 2015; 42: 619-629
        • Grossman D.
        • Fernandez L.
        • Hopkins K.
        • Amastae J.
        • Garcia S.G.
        • Potter J.E.
        Accuracy of self-screening for contraindications to combined oral contraceptive use.
        Obstetrics & Gynecology. 2008; 112: 572-578
        • Grossman D.
        • Fernández L.
        • Hopkins K.
        • Amastae J.
        • Potter J.
        Perceptions of the safety of oral contraceptives among a predominantly Latina population in Texas.
        Contraception. 2010; 81: 254-260
        • Grossman D.
        • Grindlay K.
        • Li R.
        • Potter J.E.
        • Trussell J.
        • Blanchard K.
        Interest in over-the-counter access to oral contraceptives among women in the United States.
        Contraception. 2013; 88: 544-552
        • Hopkins K.
        • Grossman D.
        • White K.
        • Amastae J.
        • Potter J.E.
        Reproductive health preventive screening among clinic vs. over-the-counter oral contraceptive users.
        Contraception. 2012; 86: 376-382
        • Jones R.
        • Sonfield A.
        Health insurance coverage among women of reproductive age before and after implementation of the Affordable Care Act.
        Contraception. 2016; 93: 386-391
        • Knowledge Networks
        KnowledgePanel® design summary.
        2013 (Available:) (Accessed: May 1, 2017)
        • Landau S.
        • Tapias M.
        • Taylor McGhee B.
        Birth control within reach: A national survey on women’s attitudes toward and interest in pharmacy access to hormonal contraception.
        Contraception. 2006; 74: 463-470
        • Liang S.-Y.
        • Grossman D.
        • Phillips K.A.
        User characteristics and out-of-pocket expenditures for progestin-only versus combined oral contraceptives.
        Contraception. 2012; 86: 666-672
        • Murphy P.
        • Kirkman A.
        • Hale R.W.
        A national survey of women's attitudes toward oral contraception and other forms of birth control.
        Women's Health Issues. 1995; 5: 94-99
        • Oral Contraceptives Over-the-Counter Working Group
        Will insurance cover an OTC birth control pill?.
        (Available:) (Accessed: May 1, 2017)
        • Potter J.E.
        • McKinnon S.
        • Hopkins K.
        • Amastae J.
        • Shedlin M.G.
        • Powers D.A.
        • Grossman D.
        Continuation of prescribed compared with over-the-counter oral contraceptives.
        Obstetrics & Gynecology. 2011; 117: 551-557
        • Potter J.E.
        • White K.
        • Hopkins K.
        • Amastae J.
        • Grossman D.
        Clinic versus over-the-counter access to oral contraception: choices women make along the US-Mexico border.
        American Journal of Public Health. 2010; 100: 1130-1136
        • Shotorbani S.
        • Miller L.
        • Blough D.K.
        • Gardner J.
        Agreement between women's and providers' assessment of hormonal contraceptive risk factors.
        Contraception. 2006; 73: 501-506
        • Sonfield A.
        • Tapales A.
        • Jones R.K.
        • Finer L.B.
        Impact of the federal contraceptive coverage guarantee on out-of-pocket payments for contraceptives: 2014 update.
        Contraception. 2015; 91: 44-48
        • Trussell J.
        Contraceptive failure in the United States.
        Contraception. 2011; 83: 397-404
        • United States Census Bureau
        American Community Survey.
        United States Census Bureau, Washington, DC2013
        • Upadhya K.K.
        • Santelli J.S.
        • Raine-Bennett T.R.
        • Kottke M.J.
        • Grossman D.
        Over-the-counter access to oral contraceptives for adolescents.
        Journal of Adolescent Health. 2017; 60: 634-640
        • Walls J.
        • Gifford K.
        • Ranji U.
        • Salganicoff A.
        • Gomez I.
        Medicaid coverage of family planning benefits: results from a state survey.
        (Available:) (Accessed: May 1, 2017)
        • White K.
        • Potter J.E.
        • Hopkins K.
        • Fernandez L.
        • Amastae J.
        • Grossman D.
        Contraindications to progestin-only oral contraceptive pills among reproductive-aged women.
        Contraception. 2012; 86: 199-203
        • Yeager D.S.
        • Krosnick J.A.
        • Chang L.
        • Javitz H.S.
        • Levendusky M.S.
        • Simpser A.
        • Wang R.
        Comparing the accuracy of RDD telephone surveys and internet surveys conducted with probability and non-probability samples.
        Public Opinion Quarterly. 2011; 75: 709-747

      Biography

      Kate Grindlay, MSPH, is an Associate at Ibis Reproductive Health and Project Director of the Free the Pill project. She oversees the implementation of a program to move an oral contraceptive pill over the counter in the United States.

      Biography

      Daniel Grossman, MD, is the Director of Advancing New Standards in Reproductive Health at the University of California, San Francisco. His research focuses on improving access to contraception and safe abortion and evaluating the impact of integrating reproductive health and HIV services.